Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • 2019
  • Article
  • Journal of Behavioral Economics for Policy

Pay-for-Monopoly?: An Assessment of Reverse Payment Deals by Pharmaceutical Companies

By: Sana Rafiq and Max Bazerman
  • Format:Electronic
  • | Pages:7
ShareBar

Abstract

Abstract Over the past eighteen years, pharmaceutical firms have developed a blueprint to impede competition in order to maintain their monopoly profits. This scheme, termed pay-for-delay, involves direct or indirect payment of money from a branded-drug manufacturer to a generic-drug producer to stay out of market. In most cases, the payment is shrouded as a side deal, where the generic-drug entrant agrees to stay out of the market in return for overpayment on some unrelated agreement from the branded drug company. These agreements are signed at the same time, or even within the same legal agreement. While the Federal Trade Commission has often asserted that these agreements restrict trade by keeping the generic off the market at the expense of consumers, traditional expert economists have developed a number of defenses for such practices. Drawing on insights from behavioral economics, we argue that these agreements are very unlikely to be pro-competitive. We suggest solutions, both judicial and legislative, that would lead generic drugs to the market faster, providing more medicine to those that need it at a more affordable price.

Keywords

Monopoly; Policy; Competition; Agreements and Arrangements; Pharmaceutical Industry

Citation

Rafiq, Sana, and Max Bazerman. "Pay-for-Monopoly? An Assessment of Reverse Payment Deals by Pharmaceutical Companies." Journal of Behavioral Economics for Policy 3, no. 1 (2019): 37–43.
  • Read Now

About The Author

Max H. Bazerman

Negotiation, Organizations & Markets
→More Publications

More from the Authors

    • 2022
    • Behavioral Science & Policy

    Leadership & Overconfidence

    By: Don A Moore and Max H. Bazerman
    • 2022
    • Faculty Research

    Complicit: How We Enable the Unethical and How to Stop

    By: Max H. Bazerman
    • 2022
    • Faculty Research

    Redirecting Rawlsian Reasoning Toward the Greater Good

    By: Joshua D. Greene, Karen Huang and Max Bazerman
More from the Authors
  • Leadership & Overconfidence By: Don A Moore and Max H. Bazerman
  • Complicit: How We Enable the Unethical and How to Stop By: Max H. Bazerman
  • Redirecting Rawlsian Reasoning Toward the Greater Good By: Joshua D. Greene, Karen Huang and Max Bazerman
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College